ecrin-mdr-crcClinical2022IPD Sharing (as of February 2023): NoMetastatic Colorectal CancerColorectal NeoplasmsMetastatic Colorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2399114China2ES104ECRIN MDRActive, not recruitingfalseA Study of ES104 in Patients With Metastatic Colorectal CancerThe purpose of this open-label, Multicenter Phase I/II study is to evaluate the safety, tolerability, preliminary anti-tumor efficay, pharmacokinetics, anti-drug antibodies and biomarkers of ES104 in patients with unresectable locally advanced or metastatic colorectal cancer who have failed systemic therapies.2022-02-152399114NCT05167448